High Intensity Focused Ultrasound (HIFU) Market Report 2025

The high-intensity focused ultrasound market size has grown rapidly in recent years. It will grow from $1.49 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth during the historic period can be attributed to increased healthcare spending, a growing demand for outpatient procedures, a rise in clinical research and trials, a higher prevalence of chronic liver diseases and pancreatic cancers, and expanded investments by medical device manufacturers.

The high-intensity focused ultrasound market size is expected to see rapid growth in the next few years. It will grow to $2.5 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The anticipated growth in the forecast period can be attributed to the rising prevalence of cancer, increasing preference for minimally invasive procedures, greater awareness of non-invasive treatment options, a growing incidence of uterine fibroids and adenomyosis, and an expanding geriatric population. Key trends expected during this time include technological progress in real-time imaging guidance, improvements in transducer technology, advancements in thermal monitoring systems, technology-enhanced user interfaces and software platforms, and the development of high-power and multi-frequency ultrasound transducers.

The increasing prevalence of prostate cancer is anticipated to drive the growth of the high-intensity focused ultrasound (HIFU) market in the coming years. Prostate cancer is a malignant tumor that develops in the prostate gland of men, often growing slowly but with the potential to become aggressive and spread if not treated. The primary factor behind the rise in prostate cancer cases is the aging population, as the risk of developing the disease increases significantly with age. HIFU plays a crucial role in treating prostate cancer by using focused ultrasound waves to produce intense heat that specifically targets and destroys cancerous tissue in the prostate while preserving surrounding healthy tissue. For example, in October 2024, the National Health Service, a government department in the UK, reported that prostate cancer was the most commonly diagnosed cancer in 2022, with 54,732 new cases - an increase of 11,354 from 2021. As a result, the growing prevalence of prostate cancer is fueling the expansion of the HIFU market.

Leading companies in the high-intensity focused ultrasound (HIFU) market are developing innovative non-invasive surgical technologies to enhance treatment precision, minimize patient recovery time, and reduce the risks associated with traditional surgical methods. These non-invasive surgical devices treat internal conditions without requiring incisions, instead using methods such as focused ultrasound or lasers to target tissues with accuracy. For instance, in April 2025, EDAP TMS S.A., a France-based manufacturer of minimally invasive medical devices, launched the advanced focal one i system to improve the precision and effectiveness of non-invasive prostate cancer therapy. This system integrates advanced imaging technologies like PSMA PET and micro-ultrasound with AI-powered algorithms to deliver personalized robotic HIFU therapy. It also offers improved workflow integration and features for remote collaboration, aiming to enhance treatment accuracy, reduce side effects, and expand access to expert care through real-time streaming and remote support.

In April 2023, Florida Atlantic University (FAU), a public research university in the United States, entered into a partnership with Insightec Ltd. to promote research and clinical use of focused ultrasound, including both high-intensity and low-intensity applications, for treating neurological conditions such as Parkinson’s disease and Alzheimer’s disease. Insightec Ltd. is a medical device company based in Israel that specializes in high-intensity focused ultrasound (HIFU) technology.

Major players in the high intensity focused ultrasound (hifu) market are Siemens Healthineers AG., Koninklijke Philips N.V., GE HealthCare Technologies Inc., Merz Pharma GmbH & Co. KGaA, Insightec Ltd., EDAP TMS S.A., Chongqing Haifu Medical Technology Co. Ltd., SuperSonic Imagine S.A., Blatek Industries Incorporated, Alpinion Medical Systems Co. Ltd., ILJIN Holdings Co. Ltd., Sonablate Corp., SonaCare Medical LLC., Lynton Lasers Ltd., Profound Medical Corp., Mianyang Sonic Electronic LTD., Verasonics Inc., FUS Instruments Inc., Sonic Concepts Inc., Theraclion S.A.

North America was the largest region in the high intensity focused ultrasound market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in high-intensity focused ultrasound (HIFU) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the high-intensity focused ultrasound (HIFU) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The high-intensity focused ultrasound (HIFU) market consists of revenues earned by entities by providing services such as cancer treatment, fibroid treatment, neurological disorders, pain management, non-surgical facelifts, and body contouring. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-intensity focused ultrasound (HIFU) market also includes sales of software and imaging modules, portable or compact high-intensity focused ultrasound devices, and high-intensity focused ultrasound therapy systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The high-intensity focused ultrasound market research report is one of a series of new reports that provides high-intensity focused ultrasound market statistics, including the high-intensity focused ultrasound industry's global market size, regional shares, competitors with the high-intensity focused ultrasound market share, detailed high-intensity focused ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the high-intensity focused ultrasound market. This high-intensity focused ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

High-intensity focused ultrasound (HIFU) is a non-invasive therapeutic method that utilizes concentrated ultrasound waves to produce localized heat, effectively destroying targeted tissue while preserving the surrounding healthy areas. It is widely applied in the treatment of conditions such as tumors, uterine fibroids, and certain cancers, including prostate and liver cancer.

The primary types of HIFU devices include standalone HIFU systems, portable HIFU devices, combination HIFU systems, robotic HIFU systems, and ultrasound-guided HIFU devices. Standalone HIFU devices are self-contained systems that operate independently, without the need for additional imaging or surgical equipment. These treatments can be conducted through noninvasive or minimally invasive approaches. HIFU is used in a range of applications, including uterine fibroids, prostate cancer, essential tremor, dermatology, breast cancer, glaucoma, back pain, and facetogenic conditions. It is commonly utilized by various end users such as hospitals, ambulatory surgical centers, clinics, research organizations, and home care environments.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.